大血小板与小血小板:(何时)它们有差异?
本文综述了不同大小血小板在血栓性、年龄及与疾病关联方面的研究,指出血小板大小增加曾被认为是年轻且更具反应性亚群的特征,但后续研究对此提出质疑;MPV变化见于免疫性血小板减少症、心血管疾病、动脉粥样硬化、静脉血栓栓塞、慢性肺病、脓毒症、癌症相关血栓及自身免疫性疾病等。
要点
- 血小板大小增加与年轻、反应性亚群的传统关联受到研究质疑。
- MPV变化见于免疫性血小板减少症、心血管疾病、静脉血栓栓塞等多种疾病。
- 综述聚焦大、小血小板在血栓性、年龄及疾病关联方面的争议。
核心结论
- 大血小板与小血小板在血栓性、年龄及疾病关联方面存在研究争议。
- MPV变化与多种疾病相关,但血小板大小增加的生物学意义尚未明确。
研究设计与样本
- 综述性文章,总结关于不同大小血小板已知文献,聚焦血栓性、年龄及MPV与所述疾病的关联。
主要发现
- 血小板大小增加曾被认为是年轻且更具反应性亚群的特征,但后续研究对此提出质疑。
- MPV变化见于免疫性血小板减少症、心血管疾病、动脉粥样硬化、静脉血栓栓塞、慢性肺病、脓毒症、癌症相关血栓及自身免疫性疾病等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Platelets are most important in providing cellular hemostasis but also take part in inflammation and immune processes. Increased platelet size has been regarded as a feature describing a young and more reactive subpopulation until studies were published which questioned this concept. Moreover, changes of platelet size given by the mean platelet volume (MPV) were described for immune thrombocytopenia, cardiovascular disease, atherosclerosis, venous thromboembolism, chronic lung disease, sepsis, cancer-associated thrombosis, autoimmune disorders, and others. This review summarizes the literature on what is known about platelets with different size and describes controversies of studies with large and small platelets putting a focus on their thrombogenicity, age, and on the association of MPV with the mentioned diseases.
引用
- Handtke S, Thiele T. Large and small platelets-(When) do they differ? J Thromb Haemost. 2020. PMID: 32108994. doi:10.1111/jth.14788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。